Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Other Non-Current Assets (2017 - 2025)

Adma Biologics' Other Non-Current Assets history spans 13 years, with the latest figure at $8.6 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 52.02% year-over-year to $8.6 million; the TTM value through Dec 2025 reached $8.6 million, up 52.02%, while the annual FY2025 figure was $8.6 million, 52.02% up from the prior year.
  • Other Non-Current Assets reached $8.6 million in Q4 2025 per ADMA's latest filing, down from $8.8 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $9.1 million in Q2 2025 to a low of $2.2 million in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $5.4 million, with a median of $5.0 million recorded in 2022.
  • The largest YoY upside for Other Non-Current Assets was 93.04% in 2021 against a maximum downside of 35.85% in 2021.
  • A 5-year view of Other Non-Current Assets shows it stood at $4.1 million in 2021, then rose by 17.27% to $4.8 million in 2022, then dropped by 2.1% to $4.7 million in 2023, then increased by 21.13% to $5.7 million in 2024, then skyrocketed by 52.02% to $8.6 million in 2025.
  • Per Business Quant, the three most recent readings for ADMA's Other Non-Current Assets are $8.6 million (Q4 2025), $8.8 million (Q3 2025), and $9.1 million (Q2 2025).